Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP1 | P29466 | 1/20 | 0.59 |
| ▸ | CASP7 | P55210 | 1/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.59 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.56 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.56 |
| ▸ | SRD5A1 | P18405 | 2/20 | 0.55 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.55 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.52 |
| ▸ | GRM5 | P41594 | 1/20 | 0.49 |
| ▸ | METAP1 | P53582 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | TDP2 | O95551 | 1/20 | 0.47 |
| ▸ | S100A4 | P26447 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 2/20 | 0.46 |
| ▸ | MAOB | P27338 | 2/20 | 0.46 |
| ▸ | TYMS | P04818 | 1/20 | 0.46 |
| ▸ | PRKCI | P41743 | 1/20 | 0.46 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.45 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31108080 | 1.00 | CASP1 (0.59) | CASP1CASP7HSD17B10PARP10PARP11 | |
| SCHEMBL2065611 | 0.88 | MAOA (0.59) | CASP1CASP7HSD17B10PARP10PARP11 | |
| SCHEMBL29521431 | 0.88 | MAOA (0.59) | CASP1CASP7HSD17B10PARP10PARP11 | |
| SCHEMBL207834 | 0.88 | MAOA (0.61) | CASP1CASP7HSD17B10PARP10PARP11 | |
| SCHEMBL570706 | 0.88 | MAOA (0.59) | CASP1CASP7HSD17B10PARP10PARP11 | |
| SCHEMBL7839573 | 0.84 | TDP1 (0.63) | PARP10PARP11SRD5A1SRD5A2METAP1 | |
| SCHEMBL31268305 | 0.84 | SRD5A1 (0.64) | PARP10PARP11SRD5A1SRD5A2METAP1 | |
| SCHEMBL204100 | 0.84 | SRD5A1 (0.64) | PARP10PARP11SRD5A1SRD5A2METAP1 | |
| SCHEMBL29804236 | 0.83 | PBRM1 (0.64) | CASP1CASP7HSD17B10PARP10PARP11 | |
| SCHEMBL27286 | 0.83 | PBRM1 (0.64) | CASP1CASP7HSD17B10PARP10PARP11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1685 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115417816-B | Preparation method of 3, 6-dibromo-1-chloro-isoquinoline | 江苏南大光电材料股份有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-115650886-A | Oxime sulfonate photoacid generators and use of resist compositions | 瑞红(苏州)电子化学品股份有限公司 | 2023-01-31 | — | — | CN | claimed |
| CN-115572262-A | Isoquinoline derivative and preparation method thereof | 厦门沃克沃德医药科技有限公司 | 2023-01-06 | — | — | CN | claimed |
| CN-113861113-B | Preparation and application of fused ring pyridine compound and derivative thereof | 中国科学院福建物质结构研究所 | 2022-12-06 | — | — | CN | claimed |
| CN-115417816-A | Preparation method of 3,6-dibromo-1-chloro-isoquinoline | 江苏南大光电材料股份有限公司 | 2022-12-02 | — | — | CN | claimed |
| CN-110240537-B | Indene oxyacetic acid compound and preparation method and application thereof | 成都阿奇生物医药科技有限公司 | 2022-06-21 | — | — | CN | claimed |
| CN-110590642-B | Electroluminescent material with indenone as electron acceptor and its application | 大连理工大学 | 2022-06-07 | — | — | CN | claimed |
| CN-114163301-A | Preparation method of benzo [ B ] fluorene derivative and derivative thereof | 陕西维世诺新材料有限公司 | 2022-03-11 | — | — | CN | claimed |
| CN-113861113-A | Preparation and application of fused ring pyridine compound and derivative thereof | 中国科学院福建物质结构研究所 | 2021-12-31 | — | — | CN | claimed |
| CN-113321617-A | Red light thermal induction delay fluorescent material, preparation method thereof and organic electroluminescent device | 中国科学院长春应用化学研究所 | 2021-08-31 | — | — | CN | claimed |
| CN-110615783-B | Electroluminescent material with pyrazinoindenone as electron acceptor and application thereof | 大连理工大学 | 2021-04-20 | — | — | CN | claimed |
| CN-112574078-A | 2-sulfuryl-2, 3-dihydro-1-indanone and derivatives and synthesis method thereof | 湖南工程学院 | 2021-03-30 | — | — | CN | claimed |
| CN-109569730-B | Catalyst and application thereof | 江苏师范大学 | 2021-01-22 | — | — | CN | claimed |
| CN-110615783-A | Electroluminescent material with pyrazinoindenone as electron acceptor and application thereof | 大连理工大学 | 2019-12-27 | — | — | CN | claimed |
| CN-110590642-A | Electroluminescent material with indenone as electron acceptor and its application | 大连理工大学 | 2019-12-20 | — | — | CN | claimed |
| US-10092786-B2 | Fire extinguishing composition comprising aldoketones compound | XI'AN WESTPEACE FIRE TECHNOLOGY CO., LTD. (CN) | 2018-10-09 | — | — | US | claimed |
| US-20160332016-A1 | Fire Extinguishing Composition Comprising Aldoketones Compound | NANO FIRE, LLC | 2016-11-17 | — | — | US | claimed |
| US-5618982-A | SIMPLE INDUSTRIAL PROCESS OF CATALYZING IN PRESENCE OF METALLIC PHOSPHATES | RHONE-POULENC CHIMIE (FR) | 1997-04-08 | — | — | US | claimed |
| US-20260146035-A1 | FUSED BICYCLIC COMPOUNDS AND THEIR USE AS MER AND AXL INHIBITORS | DONG-A ST CO., LTD. (KR) | 2026-05-28 | — | — | US | disclosed |
| US-4738972-A | Hypoglycemic thiazolidinediones | PFIZER INC. (US) | 1988-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260146035-A1 | FUSED BICYCLIC COMPOUNDS AND THEIR USE AS MER AND AXL INHIBITORS | AXL, ERBB2, ERBB3 | CASP1 1376/4885CASP7 2522/4885HSD17B10 4424/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.